HENRY CHRISTIAN O
SEC Form 4 insider trading activity
HENRY CHRISTIAN O has filed 7 SEC Form 4 filings (15 transaction rows) across 3 companies, including WVE, DNA, PACB, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.
On the most recent filing, HENRY CHRISTIAN O is listed as Director at Ginkgo Bioworks Holdings, Inc. Inside the rolling window, HENRY CHRISTIAN O reported no open-market purchases and 5 open-market sales totaling $2.2M in DNA and PACB and WVE. The largest disclosed transaction in the window is a sale of 93,445 WVE shares on Dec 8, 2025, worth $1.4M.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
3
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has HENRY CHRISTIAN O made?
HENRY CHRISTIAN O has filed 7 SEC Form 4 filings (15 transaction rows) across 3 companies, including WVE, DNA, PACB since 2025.
Which companies does HENRY CHRISTIAN O trade?
HENRY CHRISTIAN O has filed SEC Form 4 disclosures for 3 companies, including WVE, DNA, PACB.
When was HENRY CHRISTIAN O's most recent SEC Form 4 filing?
HENRY CHRISTIAN O's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.
What is HENRY CHRISTIAN O's total buy and sell value in the current window?
Inside the rolling retention window, HENRY CHRISTIAN O bought $0 and sold $2.2M based on SEC Form 4 filings.
What was HENRY CHRISTIAN O's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 93,445 WVE shares on 2025-12-08, worth $1.4M, per SEC Form 4 filings.